All In Biotech

Drug Trial Radar · NCT01156571

A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)

A Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention (CHAMPION PHOENIX)

Last checked: Nov 20, 2026Latest source record: Feb 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 11,145 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

11,145

Actual

Start

Sep 2010

Primary completion

Dec 2012

Study completion Dec 2012

Sponsor

Lead sponsor
The Medicines CompanyIndustry
Sponsor type
Industry
First posted
Jul 5, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is designed to compare the efficacy and safety profile of cangrelor to standard of care in patients require percutaneous coronary intervention (PCI).

Conditions

  • Atherosclerosis
  • Percutaneous Coronary Intervention
  • Acute Coronary Syndrome

Interventions

  • cangrelor P2Y12 (platelet) inhibitorDrug

  • Clopidogrel - 300 or 600 mg (study arm)Drug

    Over encapsulated tablets.

  • Clopidogrel 600 mg post cangrelorDrug

    over-encapsulated clopidogrel (600 mg)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Composite Incidence of All-cause Mortality, Myocardial Infarction (MI), Ischemia-driven Revascularization (IDR) and Stent Thrombosis (ST)Time frame: 48 hours after randomization

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Anderson Area Medical Center

    Anderson, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.